Yatırımcı.AI

BISTTRY12:13Live

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.

MEDTR Ratio Analysis: P/E, P/B, EV/EBITDAMeditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.

Main MarketChemicals, Petroleum, Rubber and Plastics
18.400.38 (2.11%)
Volume
TRY 3.1M
Day range
18.02 – 18.96
Previous close
18.02
Market cap
TRY 2.2B

Last updated: Source: Borsa Istanbul, 15-minute delayed

35 key ratios for Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. (MEDTR) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E179.33
P/B0.62
EV/EBITDA5.10
Dividend yield0.66%
Beta—
Earnings per share0.1 TL
Book value per share29.6 TL
EBITDA319.7M TL
Net profit−73.4M TL
Operating profit111.1M TL
Operating profit before finance costs130.1M TL
Net working capital1.6B TL
Gross margin35.58%
Operating margin4.97%
Net margin−3.29%
Return on assets0.28%
Return on equity0.34%
Current ratio3.77
Quick ratio2.59
Cash ratio—
Leverage ratio16.46
Debt to equity0.20
Debt to assets0.16
Fixed assets to equity0.61
Short-term debt share—
Interest coverage—
Receivables turnover1.03
Days sales outstanding354
Inventory turnover2.17
Days inventory outstanding168
Payables turnover3.60
Days payables outstanding101
Working capital turnover1.44
Equity turnover0.63
Asset turnover0.53

Frequently Asked Questions

MEDTR has a P/E ratio of 179.33, a P/B ratio of 0.62 and an EV/EBITDA of 5.10.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.